Quality‐of‐life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new‐onset epilepsy: Findings from the SANAD trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1528-1167|56|3|460-472

ISSN: 0013-9580

Source: EPILEPSIA, Vol.56, Iss.3, 2015-03, pp. : 460-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract